NASDAQ: SUPXSuper X Ai Technology Ltd Stock
$10.09+0.12 (+1.2%)
Updated Jun 30, 2025
SUPX Price
$10.09
Fair Value Price
$0.36
Market Cap
$130.94M
52 Week Low
$2.75
52 Week High
$14.42
P/E
-19.22x
P/B
32.44x
P/S
24.62x
PEG
N/A
Dividend Yield
N/A
Revenue
$1.98M
Earnings
-$6.73M
Gross Margin
23.1%
Operating Margin
-350.21%
Profit Margin
-340.3%
Debt to Equity
0.59
Operating Cash Flow
-$4M
Beta
-0.12
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A
SUPX Overview
Supertex, Inc. was a publicly traded semiconductor company specializing in high-voltage analog and mixed-signal integrated circuits (ICs). The company focused on applications in medical imaging, LED lighting, telecommunications, and industrial electronics.
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine SUPX's potential to beat the market
CHold
- Stocks with a Zen Rating of Hold (C) had an average return of +7.53% per year. Learn More
Zen Rating Component Grades
C
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Industry: Engineering & Construction
Industry Rating
A
SUPX
Ranked#28 of 43
Ranked#28 of 43
Top Ranked Stocks in Industry
| Name / Ticker | Price | Zen Rating |
|---|---|---|
| $77.94 | A | |
| $62.51 | A | |
| $46.78 | A |
Be the first to know about important SUPX news, forecast changes, insider trades & much more!
SUPX News
Overview
Due Diligence Score
–
Industry Average (33)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how SUPX scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
SUPX ($10.09) is overvalued by 2,696.95% relative to our estimate of its Fair Value price of $0.36 based on Discounted Cash Flow (DCF) modelling
Below Fair Value Valuation
SUPX ($10.09) is not significantly undervalued (2,696.95%) relative to our estimate of its Fair Value price of $0.36 based on Discounted Cash Flow (DCF) modelling, when including a healthy margin of safety
Significantly Below Fair Value Valuation
SUPX is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more SUPX due diligence checks available for Premium users.
Valuation
SUPX fair value
Fair Value of SUPX stock based on Discounted Cash Flow (DCF)
Price
$10.09
Fair Value
$0.36
Overvalued by
2,696.95%
SUPX ($10.09) is overvalued by... subscribe to Premium to read more.
Below Fair Value Valuation
SUPX ($10.09) is not significantly... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
SUPX is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
SUPX price to earnings (PE)
For valuing profitable companies with steady earnings
Company
-19.22x
Industry
40.93x
Market
32.47x
SUPX price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
32.44x
Industry
5.09x
SUPX is poor value based... subscribe to Premium to read more.
P/B vs Industry Valuation
SUPX's financial health
Profit margin
Revenue
$0.0
Net Income
$0.0
Profit Margin
0%
SUPX's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
SUPX's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$6.4M
Liabilities
$2.4M
Debt to equity
0.59
SUPX's short-term assets ($4.33M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
SUPX's short-term assets ($4.33M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
SUPX's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
N/A
Investing
N/A
Financing
N/A
SUPX's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials
SUPX vs Engineering & Construction Stocks
Super X Ai Technology Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.